243 related articles for article (PubMed ID: 20412490)
1. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
Grattan MJ; McCrindle BW
Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure.
Okano S; Sugimoto M; Takase M; Iseki K; Kajihama A; Azuma H
Intern Med; 2016; 55(12):1611-4. PubMed ID: 27301514
[TBL] [Abstract][Full Text] [Related]
3. Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome.
Mizuochi T; Suda K; Seki Y; Yanagi T; Yoshimoto H; Kudo Y; Iemura M; Tanikawa K; Matsuishi T
Pediatr Int; 2015 Apr; 57(2):e39-41. PubMed ID: 25868959
[TBL] [Abstract][Full Text] [Related]
4. Protein-losing enteropathy and the Fontan operation.
Johnson JN; Driscoll DJ; O'Leary PW
Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
[TBL] [Abstract][Full Text] [Related]
5. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
[TBL] [Abstract][Full Text] [Related]
6. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
[TBL] [Abstract][Full Text] [Related]
7. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
[TBL] [Abstract][Full Text] [Related]
8. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation.
Bhagirath KM; Tam JW
Ann Thorac Surg; 2007 Dec; 84(6):2110-2. PubMed ID: 18036954
[TBL] [Abstract][Full Text] [Related]
9. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
Yetman AT; Everitt MD
Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
[TBL] [Abstract][Full Text] [Related]
10. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease.
Ringel RE; Peddy SB
Am J Cardiol; 2003 Apr; 91(8):1031-2, A9. PubMed ID: 12686359
[No Abstract] [Full Text] [Related]
12. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
Turner Z; Lanford L; Webber S
Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
[TBL] [Abstract][Full Text] [Related]
13. Protein-losing enteropathy after Fontan operation.
Rychik J
Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
[TBL] [Abstract][Full Text] [Related]
14. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
[TBL] [Abstract][Full Text] [Related]
15. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
[TBL] [Abstract][Full Text] [Related]
16. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
Ostrow AM; Freeze H; Rychik J
Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
[TBL] [Abstract][Full Text] [Related]
17. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
Uzun O; Wong JK; Bhole V; Stumper O
Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease.
Meadows J; Gauvreau K; Jenkins K
Congenit Heart Dis; 2008; 3(4):269-76. PubMed ID: 18715461
[TBL] [Abstract][Full Text] [Related]
19. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
Meadows J; Jenkins K
Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
Ono S; Ohuchi H; Miyazaki A; Yamada O
Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
